Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comments on epirubicin

N A Dobbs, C J Twelves

    Annals of Oncology : Official Journal of the European Society for Medical Oncology
    |January 1, 1994
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cellular Uptake and Efflux of Palbociclib In Vitro in Single Cell and Spheroid Models.

    The Journal of pharmacology and experimental therapeutics·2019
    Same author

    Drug delivery in a tumour cord model: a computational simulation.

    Royal Society open science·2017
    Same author

    Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Mathematical and computational models of drug transport in tumours.

    Journal of the Royal Society, Interface·2014
    Same author

    'Being there' for women with metastatic breast cancer: a pan-European patient survey.

    British journal of cancer·2013
    Same author

    Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials.

    British journal of cancer·2012
    Same journal

    The ethical obligation to use positive trial results.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same journal

    Lorlatinib: The Crown Jewel of ALK Inhibitors.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same journal

    TROP2-Directed Antibody Drug Conjugates: New First-Line Treatment for All Patients with Advanced Triple-Negative Breast Cancer?

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same journal

    When artificial intelligence learns to abstain: towards clinically responsible diagnostic support in liver pathology.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same journal

    PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block?

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    Same journal

    Refining decision making in hormone receptor-positive early-stage breast cancer: moving from static to dynamic.

    Annals of oncology : official journal of the European Society for Medical Oncology·2026
    See all related articles